Open AccessVariation in Use of High-Flow Nasal Cannula and Noninvasive Ventilation Among Patients With COVID-19
Author(s) -
Michael A. Garcia,
Shelsey W. Johnson,
Emily Sisson,
R. Christopher Sheldrick,
Vishakha Kumar,
Karen Boman,
Scott Bolesta,
Vikas Bansal,
Marija Bogojevic,
J. P. Domecq,
Amos Lal,
Smith Heavner,
Sreekanth Cheruku,
Donna Lee,
Harry L. Anderson,
Joshua L. Denson,
Ognjen Gajic,
Rahul Kashyap,
Allan J. Walkey
Publication year - 2022
Publication title -
respiratory care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.751
H-Index - 89
eISSN - 1943-3654
pISSN - 0020-1324
DOI - 10.4187/respcare.09672
Subject(s) - nasal cannula , medicine , odds ratio , veterans affairs , emergency medicine , oxygen therapy , covid-19 , anesthesia , intensive care medicine , surgery , cannula , disease , infectious disease (medical specialty)
The use of high-flow nasal cannula (HFNC) and noninvasive ventilation (NIV) for hypoxemic respiratory failure secondary to COVID-19 are recommended by critical-care guidelines; however, apprehension about viral particle aerosolization and patient self-inflicted lung injury may have limited use. We aimed to describe hospital variation in the use and clinical outcomes of HFNC and NIV for the management of COVID-19.